270 related articles for article (PubMed ID: 15608675)
1. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
2. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Milde-Langosch K; Janke S; Wagner I; Schröder C; Streichert T; Bamberger AM; Jänicke F; Löning T
Breast Cancer Res Treat; 2008 Feb; 107(3):337-47. PubMed ID: 17393299
[TBL] [Abstract][Full Text] [Related]
3. Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W; Gibo DM
Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
6. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.
Adiseshaiah P; Lindner DJ; Kalvakolanu DV; Reddy SP
Cancer Res; 2007 Jul; 67(13):6204-11. PubMed ID: 17616677
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
Schröder C; Schumacher U; Müller V; Wirtz RM; Streichert T; Richter U; Wicklein D; Milde-Langosch K
Eur J Cancer; 2010 Jun; 46(9):1650-60. PubMed ID: 20226654
[TBL] [Abstract][Full Text] [Related]
8. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
Wang XY; Tan JX; Vasse M; Delpech B; Ren GS
Chin Med J (Engl); 2009 Jun; 122(11):1300-4. PubMed ID: 19567141
[TBL] [Abstract][Full Text] [Related]
10. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
11. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
12. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
13. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
[TBL] [Abstract][Full Text] [Related]
15. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells.
Kattan Z; Minig V; Leroy P; Dauça M; Becuwe P
Breast Cancer Res Treat; 2008 Mar; 108(2):203-15. PubMed ID: 17473980
[TBL] [Abstract][Full Text] [Related]
16. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
17. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.
Song Y; Qian L; Song S; Chen L; Zhang Y; Yuan G; Zhang H; Xia Q; Hu M; Yu M; Shi M; Jiang Z; Guo N
Mol Immunol; 2008 Jan; 45(1):137-43. PubMed ID: 17572495
[TBL] [Abstract][Full Text] [Related]
18. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].
Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Lu LJ; Liu G; Shen ZZ; Ding J; Shao ZM
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):389-92. PubMed ID: 16188119
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
Sommers CL; Thompson EW; Torri JA; Kemler R; Gelmann EP; Byers SW
Cell Growth Differ; 1991 Aug; 2(8):365-72. PubMed ID: 1793731
[TBL] [Abstract][Full Text] [Related]
20. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
